Skip to main content

AstraZeneca and Oxford defend Covid vaccine trials after questions raised in the U.S.

“We believe that this product will never be licensed in the U.S.,” one group of critical U.S.-based analysts wrote this week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.